105 related articles for article (PubMed ID: 10798782)
1. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
Schots R; Trullemans F; Van Riet I; Kaufman L; Hafsia A; Meddeb B; Hadj Ali ZB; Ben Abid H; Lauwers S; Van Camp B
Transplantation; 2000 Apr; 69(7):1511-4. PubMed ID: 10798782
[TBL] [Abstract][Full Text] [Related]
2. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis.
Arns da Cunha C; Weisdorf D; Shu XO; DeFor T; Pastor JD; Johnson JR
Bone Marrow Transplant; 1998 Jan; 21(2):173-80. PubMed ID: 9489635
[TBL] [Abstract][Full Text] [Related]
3. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
Vassilomanolakis M; Plataniotis G; Koumakis G; Hajichristou H; Skouteri H; Dova H; Efremidis AP
Bone Marrow Transplant; 1995 Jan; 15(1):77-80. PubMed ID: 7742759
[TBL] [Abstract][Full Text] [Related]
4. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
[TBL] [Abstract][Full Text] [Related]
5. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients.
Koc Y; Snydman DR; Schenkein DS; Miller KB
Bone Marrow Transplant; 1998 Jul; 22(2):207-9. PubMed ID: 9707033
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
8. Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Dompeling EC; Donnelly JP; Deresinski SC; Feld R; Lane-Allman EF; De Pauw BE
Eur J Cancer; 1996 Jul; 32A(8):1332-9. PubMed ID: 8869095
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Broun ER; Wheat JL; Kneebone PH; Sundblad K; Hromas RA; Tricot G
Antimicrob Agents Chemother; 1994 Mar; 38(3):576-9. PubMed ID: 8203857
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance.
Bock AM; Cao Q; Ferrieri P; Young JA; Weisdorf DJ
Biol Blood Marrow Transplant; 2013 Jan; 19(1):102-8. PubMed ID: 22940054
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
14. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.
Clemmons AB; Gandhi AS; Albrecht B; Jacobson S; Pantin J
J Oncol Pharm Pract; 2019 Mar; 25(2):326-332. PubMed ID: 29059026
[TBL] [Abstract][Full Text] [Related]
15. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
Cruciani M; Rampazzo R; Malena M; Lazzarini L; Todeschini G; Messori A; Concia E
Clin Infect Dis; 1996 Oct; 23(4):795-805. PubMed ID: 8909847
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management.
Lee SO; Kang SH; Abdel-Massih RC; Brown RA; Razonable RR
Liver Transpl; 2011 Jun; 17(6):733-41. PubMed ID: 21412966
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.
Edmond MB; Ober JF; Weinbaum DL; Pfaller MA; Hwang T; Sanford MD; Wenzel RP
Clin Infect Dis; 1995 May; 20(5):1126-33. PubMed ID: 7619987
[TBL] [Abstract][Full Text] [Related]
19. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
Avery R; Kalaycio M; Pohlman B; Sobecks R; Kuczkowski E; Andresen S; Mossad S; Shamp J; Curtis J; Kosar J; Sands K; Serafin M; Bolwell B
Bone Marrow Transplant; 2005 Mar; 35(5):497-9. PubMed ID: 15640812
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
